Boston Scientific Corp (BSX) Q2 2021 Earnings Call Transcript
BSX earnings call for the period ending June 30, 2021.
Boston Scientific(BSX)
New York Stock Exchange
BSX
$44.84
-$0.03
-0.1%
Price as of October 22, 2021, 4:00 p.m. ET
View Interactive BSX Charts
The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.
Interactive Chart
Compare BSX Stock to Peers
| Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
|---|---|---|---|---|
|
BSX
Boston Scientific
|
$44.84 | $64B | 21.6% | 99.8% |
|
ISRG |
$341.52 | $122B | 43.9% | 352.3% |
|
TDOC |
$137.79 | $22B | -35.1% | 766.6% |
|
UNH |
$449.16 | $424B | 41.0% | 237.1% |
|
VEEV |
$320.56 | $49B | 8.0% | 739.4% |
News & Analysis: Boston Scientific
The Fool has written over 300 articles on Boston Scientific.
Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript
BSX earnings call for the period ending March 31, 2021.
Boston Scientific Corp (BSX) Q4 2020 Earnings Call Transcript
BSX earnings call for the period ending December 31, 2020.
This Medical Device Maker Will Be Well Positioned Post COVID
The pandemic is only a temporary setback for this diversified global manufacturer of medical devices.
3 Top Healthcare Stocks to Buy in August
New products mean solid revenue may be ahead for these companies.
Is Boston Scientific Stock a Buy?
Newly released products will drive revenue growth, but will they benefit shareholders?
Why These Top Medical Device Stocks Have Fallen by Double Digits So Far in 2020
High demand for a single product can't sustain an industry.
Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?
The pandemic has slowed sales for the two medical device companies. Which stock is ready to rise when medical procedures return?
Boston Scientific (BSX) Q1 2020 Earnings Call Transcript
BSX earnings call for the period ending March 31, 2020.
Boston Scientific Stock Rises on Sales Increase, Positive Management Outlook
But a sharp decline in medical procedures caused a drop in first-quarter profits.
